top of page
Peptide Patch Store
💊MK-677 Pills | 25mg X 100
Product Details
Brand:
MicroPharma.us
IBUTAMOREN MK-677
| Unit Size | 25 mg/pill |
| Unit Quantity | 100 Pills |
| Molecular Formula | C28H40N4O8S2 |
| Molecular Weight | 624.77 |
| SARM | MK-677 |
| Appearance | Pills |
MK-677, or Ibutamoren, is a potent, orally-active growth hormone secretagogue, mimicking the ghrelin receptor’s natural ligand, ghrelin. It operates by binding to ghrelin receptors (GHSR) located in the brain, specifically in the pituitary gland and hypothalamus. This activation modulates the release of growth hormone (GH) and increases plasma levels of insulin-like growth factor 1 (IGF-1).
The biochemical mechanism involves the stimulation of the arcuate nucleus of the hypothalamus. This stimulation triggers a cascade of biological processes that ultimately enhance the pulsatile secretion of GH from the pituitary gland. The ghrelin receptor, being a G-protein coupled receptor (GPCR), activates the intracellular signaling pathways involving cyclic AMP (cAMP) and possibly phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway, leading to increased GH secretion.
Clinically, the rise in GH and IGF-1 from MK-677 administration can influence multiple anabolic and anti-catabolic processes. Anabolically, it can enhance muscle mass and strength by promoting myocyte proliferation and differentiation, as well as by inhibiting myostatin—a growth factor that suppresses muscle growth. Anti-catabolically, MK-677 may decrease muscle wasting in patients with catabolic conditions by antagonizing the muscle degradation pathways.
The compound also impacts metabolism and body composition through direct and indirect pathways. Its action on GH can lead to increased lipolysis—the breakdown of fats—which can potentially support fat loss. Moreover, MK-677's influence on IGF-1 levels can enhance tissue regeneration and repair, beneficial for recovery from exercise-induced damage.
On bone metabolism, MK-677 increases bone density by promoting bone turnover. This effect is primarily mediated through the increase in GH and IGF-1 levels, which enhance osteoblast activity (bone building) and possibly reduce osteoclast activity (bone resorption).
OFFICIAL PARTNERS:
bottom of page